Webinar Duration: 60 minutes
RECORDED: Access recorded version only for one participant; unlimited viewing for 6 months (Access information will be emailed 24 hours after the completion of payment)
SPEAKER: Dr. Nagina Parmar
OVERVIEW:
In order to become a safe and effective medicine, a compound has to travel through a lengthy process of rigorous testing. Over the last few decades, the amount of time required to develop and test a novel drug has increased drastically. However, the introduction of social media and digital technology into drug development have the ability to significantly expedite this process. This webinar will explore the policies and principles of using social media through the evolution of developing a pharmaceutical drug from its initial stages to its introduction into the market. This includes analyzing the methods in which pharmaceutical companies utilize social media during the planning process, identifying the best candidate for the lead compound in a drug, conducting animal and human testing, recruiting candidates for clinical trials.
The course will also be examining the manner in which pharmaceutical companies use social media for marketing and licensing purposes.
Why should you Attend: Social media has a huge impact on the pharmaceutical industries especially bringing drugs to the market safe and effective manner and reducing the overall time required for the development and approval of the drug. This webinar will explore the policies and principles of using social media through the evolution of developing a pharmaceutical drug from its initial stages to its introduction into the market.
Areas Covered in the Session:
Analyzing the methods in which pharmaceutical companies utilize social media during – the planning process
– Identifying the best candidate for the lead compound in a drug, conducting animal and human testing,
– Recruiting candidates for clinical trials.
Who Will Benefit:
– Clinical Trials Sponsors (Pharmaceutical and Academic institutions)
– Investigators
– Study coordinators
– Research Nurse coordinators
– Principle Investigators
– Senior Clinical Research Associates(CRAs)
– Clinical Research Project Manager
– Contract Research Organizations (CROs)
– Site Management Organizations (SMOs)
SPEAKER PROFILE:
Dr. Nagina Parmar has years of clinical research experience as a certified clinical research professional in academia and hospital. Her expertise as clinical research professional lies in coordinating various Phase I, II and III national and international clinical trials and investigator initiated trials. During her career as CCRP, she was also involved in developing SOPs (Standard operating Procedures), REB SOPs and research elements database. She is an active member of the Society of Clinical Research Associates (SoCRA) and Network of Networks(N2N). As an Adjunct faculty, Dr. Parmar is also involved in teaching Biology, Microbiology, Life Sciences for Clinical practice, and drug development courses at various academic institutions. Her writing appeared in more than 30 journal articles, books and reviews in various national and international journals.
As a mentor, Dr. Parmar has provided references and letter of recommendations to assist students with their endeavors. Dr. Parmar has given various career development seminars at University of Toronto to graduates and postgraduates and webinar with Association of Clinical Research Professionals (ACRP).
